CONCLUSIONS: The intravesical combination of BCG with murinized PD1-IL2v selectively increases the number of cytotoxic CD8+ TILs, but not Tregs, and improves the survival of the mice in the preclinical model of bladder cancer model. The gene discussed is CD8A; the disease is urinary bladder carcinoma.